IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,522,067 | -2.8% | 77,647 | -12.0% | 0.03% | +3.7% |
| Q2 2023 | $3,622,209 | +1243.1% | 88,282 | +1069.9% | 0.03% | +1250.0% |
| Q1 2023 | $269,694 | -7.8% | 7,546 | -2.5% | 0.00% | 0.0% |
| Q4 2022 | $292,415 | -11.1% | 7,742 | +4.2% | 0.00% | -33.3% |
| Q3 2022 | $329,000 | +19.6% | 7,431 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $275,000 | -7.1% | 7,431 | -7.1% | 0.00% | 0.0% |
| Q1 2022 | $296,000 | +17.9% | 7,998 | +27.1% | 0.00% | 0.0% |
| Q2 2021 | $251,000 | -13.7% | 6,291 | -2.9% | 0.00% | 0.0% |
| Q1 2021 | $291,000 | -16.4% | 6,476 | +5.2% | 0.00% | -33.3% |
| Q4 2020 | $348,000 | +16.4% | 6,153 | -2.2% | 0.00% | 0.0% |
| Q3 2020 | $299,000 | -34.3% | 6,291 | -18.5% | 0.00% | -25.0% |
| Q2 2020 | $455,000 | +44.0% | 7,716 | +15.3% | 0.00% | 0.0% |
| Q1 2020 | $316,000 | – | 6,693 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |